REFERENCES
- Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry 1986; 46: 117–121
- Weiss R. D., Mirin S. M., Michael J. L., et al. Psychopathology in chronic cocaine abusers. Am. J. Drug Alcohol Abuse 1986; 12: 17–29
- Nunes E. V., Quitken F. M., Klein D. F. Psychiatric diagnosis in cocaine abuse. Psychiatry Res. 1989; 28: 105–114
- Carroll K. M., Nich C., Rounsaville B. J. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. J. Nerv. Ment. Dis. 1995; 183: 251–259
- Carroll K. M., Power M. E., Bryant K., et al. One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J. Nerv. Ment. Dis. 1993; 181: 71–79
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Author, Washington, DC 1994
- Margolin A., Kosten T. R., Avants S. K., et al. A multicenter trial of buproprion for cocaine dependence in methadone maintained patients. Drug Alcohol Depend 1995; 40: 125–131
- Nunes E. V., Quitkin F. M., Brady R., et al. Antidepressant treatment in methadone maintenance patients. J. Addict. Dis. 1994; 13: 13–24
- Zeidonis D. M., Kosten T. R. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol. Bull. 1991; 27: 337–343
- Arndt I. O., Dorozynsky L., Woody G. E., et al. Desipramine treatment of cocaine dependence in methadone-maintenance patients. Arch. Gen. Psychiatry 1992; 49: 888–893
- Carroll K. M., Rounsaville B. J., Gordon L. T., et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch. Gen. Psychiatry 1994; 51: 177–187
- Nunes E. V., McGrath P. J., Quitkin F. M., et al. Imipramine treatment of cocaine abuse; possible boundaries of efficacy. Drug Alcohol Depend. 1995; 39: 185–195
- Nunes E. V., McGrath P. J., Quitken F. M., et al. Imipramine treatment of alcoholism with comorbid depression. Am. J. Psychiatry 1993; 150: 963–965
- Mason B. J., Kocsis J. H., Ritvo E. C., et al. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence and stratified on the presence or absence of major depression. JAMA 1996; 275: 761–767
- McGrath P. J., Nunes E. V., Stewart J. W., et al. Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch. Gen. Psychiatry 1996; 53: 232–240
- Woody G., McClellan T., Bedrick J. Dual diagnosis. Review of Psychiatry, J. M. Oldham, M. B. Riba. APA Press, Washington, DC 1995; 14: 83–103
- Nunes E. V., Deliyannides D., Donovan S., et al. The management of treatment-resistance in depressed patients with substance use disorders. Psychiatric Clin. North Am. 1998
- Ellingrod V. L., Perry P. J. Venlafaxine: a heterocyclic antidepressant. Am. J. Hosp. Pharmacol. 1994; 51: 3033–388
- Quitkin F. M., McGrath P. J., Stewart J. W., et al. Can the effects of antidepressants be observed in the first two weeks of treatment. Neuropsychopharmacology 1996; 15(4)390–394
- Nunes E. V. Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective. NIDA Res. Monogr. 1997; 175: 73–95
- Augustin B. G., Cold J. A., Jann M. W. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants. Pharmacotherapy 1997; 17(3)511–530
- Guelfi J. D., White C., Hackett D. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J. Clin. Psychiatry 1995; 56: 450–458
- Marcou A., Kosten T. R., Koob G. F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998; 18: 135–174